Segment Information - Summarized Financial Information for the Company's Segments (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Segment Reporting Information
Consolidated revenue	$ 60,921	$ 49,844	$ 116,082	$ 98,424
Total segment depreciation expense	359	173	673	338
Total segment amortization	739	621	1,412	1,233
Selling, general and administrative expense	28,348	11,212	58,154	22,390
Non-segment depreciation and amortization	1,098	794	2,085	1,571
Loss from operations	(18,304)	(1,116)	(36,775)	(2,869)
Operating segments
Segment Reporting Information
Consolidated revenue	60,921	49,844	116,082	98,424
Total segment direct costs	49,779	38,954	92,618	77,332
Total segment depreciation expense	283	141	535	269
Total segment amortization	738	620	1,412	1,233
Total segment operating income	10,121	10,129	21,517	19,590
Selling, general and administrative expense	28,348	11,212	58,154	22,390
Non-segment assets
Segment Reporting Information
Non-segment depreciation and amortization	77	33	138	69
Patient services | Operating segments
Segment Reporting Information
Consolidated revenue	39,109	29,786	74,166	59,408
Total segment direct costs	32,875	23,574	60,253	46,660
Total segment depreciation expense	282	139	532	266
Total segment amortization	686	568	1,307	1,128
Total segment operating income	5,266	5,505	12,074	11,354
Dispensary | Operating segments
Segment Reporting Information
Consolidated revenue	20,218	17,782	38,897	35,400
Total segment direct costs	16,754	15,237	32,078	30,360
Total segment depreciation expense	0	0	0	0
Total segment amortization	0	0	0	0
Total segment operating income	3,464	2,545	6,819	5,040
Clinical trials & other | Operating segments
Segment Reporting Information
Consolidated revenue	1,594	2,276	3,019	3,616
Total segment direct costs	150	143	287	312
Total segment depreciation expense	1	2	3	3
Total segment amortization	52	52	105	105
Total segment operating income	$ 1,391	$ 2,079	$ 2,624	$ 3,196